arrow
M

Markus Zeitlinger

Medical University of Vienna
H指数:47
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetics and target attainment of aztreonam/avibactam in plasma and tissue: A human microdialysis study

他克莫司/阿维巴坦在血浆和组织中的药代动力学及靶点达峰研究:一项人体微透析研究

2026-11-040
OA
Immediate versus staged revascularization in acute coronary syndrome and multivessel disease: a meta-analysis and meta-regression of RCTs

急性冠状动脉综合征合并多支血管病变的即刻与分阶段血运重建:一项随机对照试验的荟萃分析和meta回归

2026-05-120
OAAI
How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors

如何在接受连续性肾脏替代治疗的危重患者中进行抗菌药物药代动力学研究:一项关于所有相关药代动力学因素的范畴综述

2025-12-020
OAAI
Continuous Intravenous Nimodipine Infusion With Ethanol as Carrier in Aneurysmal Subarachnoid Hemorrhage Does Not Result in Measurable Cerebral Ethanol Levels

以乙醇为载体的持续静脉尼莫地平输注在颅内动脉瘤性蛛网膜下腔出血中不会导致可测量的脑乙醇水平

2025-06-240
OAAI
Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment

磷霉素与氯唑西林对甲氧西林敏感和甲氧西林耐药金黄色葡萄球菌的协同作用:体外和体内评估

2025-06-210
OAAI
Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers

评价局部给予双氯芬酸的系统生物利用度和药代动力学中的剂量线性:一项在健康志愿者中进行的14C微剂量研究

2025-05-080
OAAI
Endothelial ENaC as a repressor of oxidative stress and a guardian of lung capillary barrier function in bacterial and viral pneumonia

内皮ENaC作为氧化应激的抑制因子以及细菌和病毒性肺炎中肺毛细血管屏障功能守护者

2025-04-070
OA
Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial

一年后重复静脉注射LPS激发的细胞因子,细胞和临床反应的稳定性: 一项健康志愿者试验

2025-03-060
OAAI